ストックスクリーナーアプリを入手
122.95
1.75%
2.11
プレマーケット:
121.30
-1.65
-1.34%
Illumina Inc (ILMN) 最新ニュース
JPMorgan Chase Boosts Illumina Stake by 17.5% - National Today
JPMorgan Chase & Co. Acquires 124,246 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina and Labcorp expand cancer testing collaboration By Investing.com - Investing.com India
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina, Labcorp Expand Collaboration to Advance Precision Oncology Testing - marketscreener.com
Illumina and Labcorp expand cancer testing collaboration - Investing.com
Synthetic Biology Market to Reach US$ 67.47 Billion by 2033 | - openPR.com
Labcorp–Illumina cancer pact targets wider access to genomic tests - Stock Titan
Investment Report: Is Illumina Inc stock a good dividend stockPortfolio Update Report & Weekly Breakout Watchlists - baoquankhu1.vn
U.S. Bioinformatics Market Is Booming Rapidly with Strong - openPR.com
Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders - TradingView
Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Gotham Asset Management LLC Purchases 144,475 Shares of Illumina, Inc. $ILMN - MarketBeat
How Illumina’s Genomics Insurance Push And Multiomic Alliance Expansion At Illumina (ILMN) Has Changed Its Investment Story - simplywall.st
Illumina Adds Activist to Board, Names Former FDA Chief as Chair - MSN
Illumina Stock: Here’s Why Numbers Suggest a 63% Upside - TIKR.com
Illumina partners with Veritas to offer genome sequencing via insurers - Investing.com
DNA screening through health plans: Illumina’s push for preventive genomics - Stock Titan
Illumina, Inc. $ILMN Shares Sold by Ion Asset Management Ltd. - MarketBeat
Bamco Inc. NY Sells 39,378 Shares of Illumina, Inc. $ILMN - National Today
Illumina, Inc. $ILMN Stake Lessened by Cannell & Spears LLC - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Casdin Capital LLC - MarketBeat
Illumina Inc. Stock (ISIN: US4523271090) Gains on Institutional Buying and Genomic Alliance Momentum - AD HOC NEWS
Illumina (ILMN) Valuation Check As Genomic Discovery Alliance Expansion Draws Fresh Investor Interest - simplywall.st
Cardiogenetic testing at scale: the TruGenome Cardiovascular Disease Test and CardioSeq Clinical Trial - Illumina
Is It Time To Reconsider Illumina (ILMN) After Prolonged Share Price Weakness? - Yahoo Finance
Spyglass Capital Management LLC Decreases Holdings in Illumina, Inc. $ILMN - MarketBeat
Quinn Opportunity Partners LLC Sells 62,423 Shares of Illumina, Inc. $ILMN - MarketBeat
Perbak Capital Partners LLP Purchases 14,315 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina Alliance Expansion With Regeneron Fuels Multiomic Data Opportunity - simplywall.st
Illumina Inc.: Why This DNA Giant Just Got Way More Interesting for You - AD HOC NEWS
Swiss National Bank Reduces Illumina Holdings - National Today
Russell Investments Group Ltd. Boosts Stake in Illumina, Inc. $ILMN - MarketBeat
Swiss National Bank Has $43.34 Million Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Schroder Investment Management Group Sells Illumina Shares - National Today
Rep. Gilbert Ray Cisneros, Jr. Buys Illumina, Inc. (NASDAQ:ILMN) Stock - MarketBeat
Schroder Investment Management Group Sells 66,235 Shares of Illumina, Inc. $ILMN - MarketBeat
First Trust Advisors LP Sells 89,600 Shares of Illumina, Inc. $ILMN - MarketBeat
Korea Investment CORP Purchases 60,500 Shares of Illumina, Inc. $ILMN - MarketBeat
ILMN SEC FilingsIllumina Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Returns Recap: Does Illumina Inc have consistent dividend growth2026 Action & Long-Term Investment Growth Plans - baoquankhu1.vn
Illumina's new connected multiomics platform set to boost its stock - MSN
Illumina partnership aims to speed rare disease diagnosis in Florida - AADC News
Illumina Stock Climbs 44.8% in a Year: What's Driving the Rally? - The Globe and Mail
Bioinformatics Market to Reach US$ 29.1 Billion by 2031 Growing - openPR.com
Capital International Inc. CA Boosts Stake in Illumina - National Today
Capital International Inc. CA Boosts Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
Inceptionr LLC Invests in Illumina, Inc. - National Today
Here’s Why Illumina Stock Could Continue Its 44% Recovery Into 2026 - TIKR.com
Capital World Investors Acquires 3,331,542 Shares of Illumina, Inc. $ILMN - MarketBeat
Capital International Sarl Buys 24,055 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Stock Holdings Increased by Capital International Ltd. CA - MarketBeat
Epigenetics Market to Reach US$ 7.10 Billion by 2033 at 14.8% CAGR - openPR.com
Inceptionr LLC Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
How Singapore is solidifying its role at the forefront of global genomics - Illumina
Illumina (ILMN) CLO Scott Davies awarded RSUs and performance stock units - Stock Titan
Illumina (ILMN) SVP awarded restricted stock and multi-metric performance units - Stock Titan
Illumina (NASDAQ: ILMN) grants stock and performance units to senior executive - Stock Titan
Illumina (NASDAQ: ILMN) CEO receives new stock and performance share grants - Stock Titan
Here's Why Illumina (ILMN) is a Strong Momentum Stock - Yahoo Finance
Neuberger Berman Group Boosts Illumina Stake - National Today
Neuberger Berman Group LLC Purchases 8,135 Shares of Illumina, Inc. $ILMN - MarketBeat
Neo Ivy Capital Management Invests $1.83 Million in Illumina, Inc. $ILMN - MarketBeat
Illumina Regeneron Alliance Targets Multiomics And Raises Valuation Questions - Yahoo Finance
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina Stock Hits Day High with Strong 5.54% Intraday Surge - Markets Mojo
1.70%
大文字化:
|
ボリューム (24 時間):